Skip to main content
Caplight Logo









Omegga

Omegga

Private
MunichFrontier & Industrial Techhttps://omegga.com/

Last Round

Seed

Apr 24, 2026

Total Funding Raised

$14.51M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Omegga is a biotech company that has developed a non-invasive, AI-powered spectroscopy technology for early sex determination in chicken embryos to end chick culling.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Computer Vision, Smart Manufacturing, Sensors, Circular Economy

Business Model

B2B

Customer Profile

Hardware + Subscription, Usage-Based SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

in-ovo sexingchick culling alternativenon-invasive sex determinationAI embryo sexingpoultry hatchery technologyspectroscopyno-kill eggsanimal welfare technologyagritechbiotech equipmenthatchery automationhardware subscription

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Omegga Comparables

Compare Omegga with similar companies based on industry and business-model similarity.

Omegga comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MatrixSpec Solutions Inc.
88%
eggXYt
86%
In Ovo B.V.
84%

Omegga Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 24, 2026
GrantMar 19, 2024
AcceleratorSep 5, 2023
GrantAug 1, 2022

Omegga Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 24, 2026

    $12M round led by IQ Capital and Capnamic Ventures.

  • Mar 19, 2024

    Secured $2.81M from the European Innovation Council.

Recent news

Latest coverage and updates

  • is_developingJul 22, 2026

    Omegga GmbH is developing alternative in-ovo sexing technology using AI-powered absorption spectroscopy.

Omegga Filings

Explore SEC and related filing metadata, where available.

Omegga filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Omegga's valuation, stock price, and market status.

Is Omegga a public or private company?

Omegga is a private company.

What is the current stock price of Omegga?

Omegga is a private company with no public stock price. No recent secondary market data is available.

How much is Omegga worth (valuation)?

Valuation information for Omegga is not publicly available.

Can I buy Omegga stock?

Omegga shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Omegga's last funding round?

Omegga's most recent funding round was Seed on April 24, 2026.

Who are the main investors in Omegga?

Key investors in Omegga include Rockstart, IQ Capital, Capnamic Ventures.

Will Omegga IPO soon?

No public IPO plans have been announced for Omegga.

How can I track Omegga secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Omegga's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMunich
Year Founded2020
Last FundingApr 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?